MedNet Solutions Announces Latest Release Of Its Award-Winning iMedNet eClinical Solution
Systemwide Enhancements Deliver Exceptional Configurability, Performance and Efficiency
MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is proud to announce the latest release of iMedNet™ eClinical, its innovative, cloud-based technology platform. iMedNet provides an extremely intuitive, flexible and affordable software-as-a-service (SaaS) solution – ideal for clinical trial sponsors and CROs wishing to quickly and efficiently build studies themselves.
"This iMedNet release delivers significant new and enhanced functionality throughout the system, encompassing our easy-to-use forms designer and randomization modules, as well as our casebook manager and robust reporting toolsets," remarked M. Clareece West, Chief Operating Officer of MedNet Solutions. "At MedNet, we're dedicated to continually refining our eClinical technologies to ensure we always deliver fully compliant and validated best-in-class solutions. Our most recent iMedNet release is tangible proof of that promise to our customers."
"We're incredibly excited about the latest iMedNet release," stated John M. (Rob) Robertson, President and CEO of MedNet Solutions. "It takes our iMedNet platform to the next level in terms of convenience, speed and control, not only for our customers, but for everyone involved in the clinical research initiative. And we're not stopping there; we're working on more exciting new functionality that will be rolled out early this coming summer. Stay tuned."
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
